Mapping the liver
The University of Toronto's Gary Bader, along with University Health Network researchers Sonya MacParland, and Ian McGilvray, have collaborated on a world first: generating a “map” of all cells of the human liver. Read more.
The University of Toronto's Gary Bader, along with University Health Network researchers Sonya MacParland, and Ian McGilvray, have collaborated on a world first: generating a “map” of all cells of the human liver. Read more.
The University of Toronto's Axel Guenther’s lab has developed collagen tubes that hold potential to be developed into lab-grown bile ducts, with the aim of being able to replace this part of the organ in a patient. Read more.
Christine Bear's lab at The Hospital for Sick Children (SickKids), along with other labs, is working on treating cystic fibrosis-linked liver disease with regenerative medicine approaches. Read more.
Shinichiro Ogawa, a scientist at the McEwen Stem Cell Institute, University Health Network, is focused on the early-stage translation of the liver cells from experiment to clinical application. Read more.
For Canadians to benefit from biomedical innovations, we must build a thriving ecosystem
Innovative study unveils rare liver disease secrets
The symposium — themed “Intentional Innovation” — attracted more than 750 registrants
This alliance is set to unlock Toronto's potential as a globally-leading ecosystem for regenerative medicine
New research could transform cell therapies for incurable diseases
“The technology we are working on is exciting, as is biotech in general. There is great potential to have an impact in improving people’s mental and physical state of health, which motivates me daily.”
Choosing a lab environment that is right for you
Study offers new insights into the role of macrophages
“By building up these cell atlases across healthy brains to serve as a reference, we’re now at a point where we can apply this knowledge to try to understand brain disorders.”
Tidy up for a chance to win a free lunch and improve the health & happiness of your lab
This blog post is just one of many in Signal’s seventh annual blog carnival discussing what hurdles need to be overcome for cell and gene therapies in clinical trials to reach the marketplace and whether the system is prepared.